Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Scynexis
AddedMar 19, 2024
UpdatedJul 9, 2026
Scynexis

Scynexis

Public

Discovering, developing, and distributing pharmaceutical products for invasive fungal infections in humans. Based in Durham, US.

HQ
Jersey City, NJ, US
Founded
1999
Overview
Compare
Fundraising
Employees
Website

SCYNEXIS, Inc., founded in Durham, North Carolina, is a biotechnology company focused on discovering, developing, and distributing pharmaceutical products for the treatment of invasive fungal infections. The company's core mission is to address unmet medical needs in fungal infection treatments through innovative solutions. SCYNEXIS offers BREXAFEMME for vulvovaginal candidiasis (VVC) and recurrent VVC, and its lead product candidate, Ibrexafungerp, targets various severe fungal infections including invasive candidiasis and aspergillosis.

Notable affiliations include research collaborations with Merck Sharp & Dohme Corp. SCYNEXIS has achieved significant milestones, such as the FDA approval of BREXAFEMME, marking a new advancement in antifungal treatments. The company's impact is underscored by its commitment to providing effective therapies for challenging fungal infections, thereby improving patient outcomes and addressing critical gaps in the current treatment landscape.

Scynexis - Similar Companies

Syneos Health logo

Syneos Health

syneoshealth.com

Synereca Pharmaceuticals logo

Synereca Pharmaceuticals

Insmed logo

Insmed

insmed.com

Sydnexis logo

Sydnexis

sydnexis.com

SelectX Pharmaceuticals logo

SelectX Pharmaceuticals

Sequella logo

Sequella

MiniVax logo

MiniVax

SphynKx Therapeutics logo

SphynKx Therapeutics

Aptinyx logo

Aptinyx

aptinyx.com

Escient Pharmaceuticals logo

Escient Pharmaceuticals

Chimerix logo

Chimerix

Microbiotix logo

Microbiotix

microbiotix.com

Exodos Life Sciences logo

Exodos Life Sciences

exodosls.com

Taxis Pharmaceuticals logo

Taxis Pharmaceuticals

taxispharma.com

Sonexa Therapeutics logo

Sonexa Therapeutics

Scynexis - Quick Facts

Who are Scynexis' competitors?

Companies similar to Scynexis include Syneos Health, Synereca Pharmaceuticals, Insmed and Sydnexis.

When was Scynexis founded?

Scynexis was founded in 1999.

Where is Scynexis' headquarters located?

Scynexis' headquarters is located in Jersey City, NJ, US.

When was Scynexis' last funding round?

Scynexis' most recent funding round was for $45M (USD) in April 2022.

How much has Scynexis raised to-date?

As of Apr 22, 2022, Scynexis has raised a total of $279.3M (USD).

How many employees does Scynexis have?

Scynexis has 56 employees as of Feb 6, 2024.

Scynexis - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
Unique IDs
  • ein: 562181648
  • secCik: 0001178253
  • ticker: SCYX
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541510Computer Systems Design and Related Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541511Custom Computer Programming Services
SIC
  • 2800Chemicals And Allied Products
  • 7300Business Services
  • 2830Drugs
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 2834Pharmaceutical Preparations
  • 7371Computer Programming Services
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 21 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering